EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study

Tua Gyldenholm, Nina Madsen, Niels Katballe, Daniel Willy Kjær, Thomas Decker Christensen, Anne-Mette Hvas

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.01.002 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Tua Gyldenholm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Health, Aarhus University, Denmark…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophagectomy, Heparin, Low-Molecular-Weight, Venous Thromboembolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aarhus University Hospital, University of Aarhus Faculty of Health, Oda and Hans Svenningsen's Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recent guidelines recommend prolonged thromboprophylaxis after esophagectomy due to cancer. However, to our knowledge, no previous studies have examined if prolonged prophylaxis is superior to standard in-hospital prophylaxis. OBJECTIVES: We aimed to perform the first clinical randomized study testing the efficacy of a prolonged 1-month thromboprophylaxis with low-molecular-weight heparin vs the standard treatment. METHODS: The study was an open-label, randomized, controlled trial including patients undergoing esophagectomy. The primary endpoint was the difference in prothrombin fragment 1 + 2 (F1 + 2) levels 1 month after surgery between the standard group and the intervention group. The secondary endpoints were the incidence of venous thromboembolic events and mortality. RESULTS: The study was terminated before reaching the expected sample size of 100 patients due to low accrual. We included 79 patients. At follow-up 1 month after surgery, F1 + 2 levels did not differ between the standard group and the intervention group (P = .41). Incidence of venous thrombosis was similar in the 2 groups, with 13% in the standard group and 15% in the intervention group. Preoperative F1 + 2 levels were significantly higher in patients who developed a venous thrombosis within 1 month after surgery than in those who did not (P = .01). The odds ratio of venous thromboembolism per 50 pmol/L increase in F1 + 2 was 1.64 (95% CI, 1.17-2.54). No patients died within 1 month after surgery. CONCLUSION: No benefit of prolonged thromboprophylaxis after esophagectomy was found. Preoperative F1 + 2 levels were found to be a predictor for the incidence of postoperative thromboembolism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsEsophagectomyHeparin, Low-Molecular-WeightVenous ThromboembolismAnticoagulantsVenous ThrombosisHumansMaleFemaleMiddle AgedAgedTreatment OutcomeTime FactorsIncidenceRisk FactorsDrug Administration SchedulePeptide Fragments

Stichwörter der Autor:innen

esophageal neoplasmsprevention and controlthrombinvenous thromboembolism

Substanzen

Heparin, Low-Molecular-WeightAnticoagulantsPeptide Fragments

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Health, Aarhus University, Denmark. Electronic address: tuagyl@clin.au.dk.
  • Department of Radiology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Health, Aarhus University, Denmark; Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Health, Aarhus University, Denmark; Department of Surgery, Aarhus University Hospital, Aarhus, Denmark.
  • Faculty of Health, Aarhus University, Aarhus, Denmark.

Förderung

  • Aarhus University Hospital
  • University of Aarhus Faculty of Health
  • Oda and Hans Svenningsen's Fund
  • Aarhus Universitet

Zitieren

APA

Gyldenholm, T., Madsen, N., Katballe, N., Kjær, D. W., Christensen, T. D., & Hvas, A. M. (2025). Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.01.002

Vancouver

Gyldenholm T, Madsen N, Katballe N, Kjær DW, Christensen TD, Hvas AM. Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.01.002

BibTeX
@article{Gyldenholm2025,
  author = {Gyldenholm, Tua and Madsen, Nina and Katballe, Niels and Kjær, Daniel Willy and Christensen, Thomas Decker and Hvas, Anne-Mette},
  title = {Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.01.002}
}
Kostenlos starten →